Drugs News by Xagena Medicine

Settembre 9, 2018Febbraio 14, 2021

DrugsNews.net

https://drugsnews.net/

Il Network Xagena utilizza i cookies per offrirti un’esperienza di navigazione migliore. Usando il nostro servizio accetti l’impiego di cookie in accordo con la …

Cancer immunotherapy Cancer immunotherapy: Tecentriq for metastatic non-small cell …	Avelumab Search results for “Avelumab”. FDA has approved first …
Biktarvy Biktarvy: Bictegravir, Emtricitabine, Tenofovir Alafenamide …	Apalutamide Search results for “Apalutamide”. FDA has approved Erleada, a …
More links Drugs Xagena Drugs News – Xagena.	ASCO Value Framework … ASCO Value Framework: application in clinical scenarios …
Bavencio Search results for “Bavencio”. FDA has approved first treatment for …	Immuno-oncology therapy Immuno-oncology therapy: Opdivo for the treatment of patients with …
Bezlotoxumab Search results for “Bezlotoxumab”. Zinplava for the prevention of …	Tobi Podhaler for the treatment … Tobi Podhaler for the treatment of Pseudomonas aeruginosa …
Altri risultati in drugsnews.net »

MediExplorer.net: Medical Search Engine

Medicine, Medical Therapy, Medical Search Engine, MediExplorer.net provides advances in medicine with impact on clinical practice, Medicine News, Xagena Medical News, Search for: Medicine, Search for: Drugs, Drugs Newsletter, Medicine Newsletter, Newsletter Drugs, Newsletter Medicine, Search in Medicine :: MediExplorer, Xagena Newsletter–


Fenretinide An Italian research team found that Fenretinide, a drug related to …	Search for Vegetarian diet Search for Vegetarian diet – 1 results. Higher intake of …
Search for Ulcerative keratitis Search for Ulcerative keratitis – 1 results. Fungal keratitis among …	Multiple sclerosis Multiple sclerosis ( MS ) is a chronic disabling disease of the …
Altri risultati in mediexplorer.net »

EBM Newsletter – Evidence-based Medicine

Aprile 19, 2018

Medicina

Evidence-based Medicine ( EBM )

Primary hypertension ACE inhibitors versus angiotensin receptor blockers

Angiotensin converting enzyme inhibitors ( ACE inhibitors ) and angiotensin receptor blockers ( ARBs; sartans ) are widely prescribed for primary hypertension ( systolic blood pressure greater than 14 …

Chronic obstructive pulmonary disease: systemic corticosteroids for acute exacerbations

Acute exacerbations of chronic obstructive pulmonary disease ( COPD ) are a major cause of hospital admission and mortality. They contribute to long-term decline in lung function, physical capacity an …

Diagnosing chronic thromboembolic pulmonary hypertension

Chronic thromboembolic pulmonary hypertension is a rare and relatively poorly understood disease. It remains underdiagnosed and is often not recognized in primary and secondary care, as its symptoms a .

–

Per iscriversi alla Newsletter Evidence Medicine in inglese

–

Coloro che sono GIA’ ISCRITTI ad altre Newsletter Xagena possono accedere al Pannello di Controllo al sito XagenaWeb.it inserendo l’indirizzo e-mail con il quale ricevono le Newsletter e la Password personale [ RIPORTATA IN FONDO A OGNI NEWSLETTER ] E’ importante confermare la modifica cliccando sul tasto SALVA MODIFICA

Medical Newsletter

Aprile 19, 2018

Medicina

Evidence-based Medicine

–

EBM, una branca della Medicina che si propone di facilitare le decisioni diagnostiche e terapeutiche, con risvolti anche nella gestione delle risorse economiche

–

Discrepancy between observed rates of atherosclerotic cardiovascular disease in the WHS trial and cardiovascular risk calculator

While the pooled cohort equations from the recent American College of Cardiology / American Heart Association ( ACC/AHA ) Guideline on the Assessment of Cardiovascular Risk have overestimated cardiova …

Copeptin helps clinicians in refining risk stratification for patients with transient ischemic attack

Copeptin has been associated with recurrent cerebrovascular events after transient ischemic attack ( TIA ). In an independent cohort, researchers have evaluated copeptin for the prediction of recurren …

Statin therapy is effective at reducing the risk of contrast-induced acute kidney injury with coronary angiography

Contrast-induced acute kidney injury is an adverse outcome resulting from radiocontrast medium exposure during coronary angiography and percutaneous coronary intervention. A systematic search was c …

Inoperable patients with severe aortic stenosis: transcatheter aortic valve replacement linked to better survival and functional status

The long-term outcomes of transcatheter aortic valve replacement ( TAVR ) in inoperable patients with severe aortic stenosis remain unknown. In the Placement of Aortic Transcatheter Valves ( PARTNE …-

Per iscriversi alla Newsletter Evidence Medicine in inglese

Coloro che sono GIA’ ISCRITTI ad altre Newsletter Xagena possono accedere al Pannello di Controllo al sito XagenaWeb.it inserendo l’indirizzo e-mail con il quale ricevono le Newsletter e la Password personale [ RIPORTATA IN FONDO A OGNI NEWSLETTER ] E’ importante confermare la modifica cliccando sul tasto SALVA MODIFICA

Drugs News

Aprile 16, 2018

Medicina

Drugs :: DrugsNews.net

DrugsNews.net, Drugs Newsletter, Drugs News, EBM :: Evidence-based Medicine, Farmaci :: Allergologia, Farmaci :: Andrologia, Farmaci :: Angiologia, Farmaci :: Aritmologia, Farmaci Cardiologia, Farmaci Dermatologia, Farmaci Diabetologia, Farmaci Ematologia, Farmaci Oncologia, Farmaci Neurologia, Farmaci Pneumologia, Farmaci Reumatologia

DrugsNews.net – Drugs Xagena ×Close. DrugsNews.net. Drugs Xagena. Newsletter Xagena …	Bevacizumab associated Bevacizumab associated with … in combination with Bevacizumab …
Regorafenib Metastatic colorectal cancer: Regorafenib approved by FDA …	Immuno-oncology therapy Immuno-oncology therapy: Opdivo for the treatment of patients with …
Drugs Xagena The Chemotherapy Clinical Reference Group ( CRG ) has …	Dasabuvir Viekira Pak to treat patients with chronic HCV genotype 1 …
Afinitor Afinitor in advanced renal cell carcinoma after failure of …	Avastin FDA has begun process to remove breast cancer indication from …
Apremilast The Food and Drug Administration ( FDA ) has approved Otezla …	Cosentyx IL-17 inhibitors: Cosentyx for first-line treatment of moderate-to …
Altri risultati in drugsnews.net »